XENCARE Trademark

Trademark Overview

On Monday, April 12, 2021, a trademark application was filed for XENCARE with the United States Patent and Trademark Office. The USPTO has given the XENCARE trademark a serial number of 90639552. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, December 17, 2024. This trademark is owned by Xenex Laboratories Inc.. The XENCARE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmacological bases in the form of gels, creams, suspensions, lotions, emulsions and foams for use in compounding pharmaceutical ingredients
xencare

General Information

Serial Number90639552
Word MarkXENCARE
Filing DateMonday, April 12, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, December 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmacological bases in the form of gels, creams, suspensions, lotions, emulsions and foams for use in compounding pharmaceutical ingredients

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXenex Laboratories Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCoquitlam, BC V3K6C2
CA

Trademark Events

Event DateEvent Description
Thursday, April 15, 2021NEW APPLICATION ENTERED
Monday, July 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 1, 2021ASSIGNED TO EXAMINER
Tuesday, December 14, 2021SUSPENSION LETTER WRITTEN
Tuesday, December 14, 2021LETTER OF SUSPENSION E-MAILED
Tuesday, December 14, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, July 5, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, July 14, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 16, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, February 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, April 12, 2023SUSPENSION INQUIRY WRITTEN
Wednesday, April 12, 2023INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 12, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, July 3, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, December 5, 2023ASSIGNED TO LIE
Tuesday, December 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 27, 2023SUSPENSION LETTER WRITTEN
Wednesday, December 27, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, December 27, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, December 12, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, December 17, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

xencare foams emulsions compounding pharmaceutical ingredients lotions suspensions bases form gels